AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,248,515 | -57.4% | 17,864 | -56.2% | 0.00% | 0.0% |
| Q2 2023 | $2,930,450 | +43.1% | 40,780 | +22.9% | 0.00% | +50.0% |
| Q1 2023 | $2,047,160 | +52.3% | 33,190 | +90.5% | 0.00% | -60.0% |
| Q4 2022 | $1,343,759 | +55.9% | 17,422 | -9.8% | 0.01% | +150.0% |
| Q3 2022 | $862,000 | +5.1% | 19,323 | -9.7% | 0.00% | 0.0% |
| Q2 2022 | $820,000 | -2.3% | 21,401 | +5.5% | 0.00% | 0.0% |
| Q1 2022 | $839,000 | +9.5% | 20,282 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $766,000 | +18.2% | 20,282 | +3.1% | 0.00% | 0.0% |
| Q3 2021 | $648,000 | -51.2% | 19,670 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $1,327,000 | +19.1% | 19,670 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,114,000 | -14.4% | 19,670 | +23.1% | 0.00% | 0.0% |
| Q4 2020 | $1,302,000 | +44.3% | 15,983 | +26.2% | 0.00% | 0.0% |
| Q3 2020 | $902,000 | – | 12,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |